Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
NYSE:BIO
| Market Cap (Intraday) | 6.71B |
| Current PE | N/A |
| Forward PE | 28.49 |
| 2yr Forward PE | 25.59 |
| 10-Day MA | $248.98 |
| 50-Day MA | $238.33 |
| 200-Day MA | $290.12 |
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Stock, NYSE:BIO
1000 Alfred Nobel Drive, Hercules, California 94547
United States of America
Phone: +1.510.724.7000
Number of Employees: 7700
Description
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.